3′UTR |
3′untranslated region |
ALL |
acute lymphoblastic leukemia |
AML |
Acute myeloid leukemia |
BAALC |
brain and acute lymphoblastic leukemia |
BCP-ALL |
B-cell precursor acute lymphoblastic leukemia |
CKD6 |
cyclin dependent kinase 6 |
DFR |
disease free of recurrence |
DFS |
disease-free survival |
DR |
downregulation |
EGIL |
The European Group for the Immunologic Classification |
ETP-ALL |
Early T-cell precursor ALL |
GRα |
glucocorticoid receptor alpha |
GSI |
γ-secretase inhibitors |
JAK |
Janus kinase |
LBL |
lymphoblastic lymphoma |
miRNA |
MicroRNA |
MMP9 |
metalloproteinase 9 |
MRD |
minimal residual disease |
OE |
overexpression |
OS |
overall survival |
PBMNC |
peripheral blood mononuclear cells |
PDGF |
Platelet Derived Growth Factor |
RB1 |
retinoblastoma protein |
RFS |
relapse-free survival |
shRNA |
short hairpin RNA |
STK39 |
serine/threonine kinase 39 |
T-ALL |
T-cell acute lymphoblastic leukemia |
TLX |
T-cell leukemia homeobox 1 |
TLX3 |
homeobox 3 |